Nuveen Asset Management, LLC Seelos Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $118,621 - $216,309	-232,591 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.84 - $1.71 $702 - $1,429	836 Added 0.36%	232,591 $210,000
Q4 2021 Feb 14, 2022	SELL	$1.59 - $2.38 $57,192 - $85,608	-35,970 Reduced 13.44%	231,755 $355,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $177,651 - $303,793	105,119 Added 64.65%	267,725 $536,000
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $429,279 - $1.03 Million	162,606 New	162,606 $429,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $109M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.